Study finds digoxin may reduce breast cancer metastasis by breaking apart cancer cell clusters.

Researchers from ETH Zurich and hospitals in Switzerland have found that digoxin, a drug traditionally used for heart conditions, can reduce the size of cancer cell clusters in breast cancer patients, potentially lowering metastasis risk. The drug weakens the cancer cells' sodium-potassium pumps, causing the clusters to break apart, though it does not eliminate existing tumors. This breakthrough, published in Nature Medicine, could lead to new treatments for metastatic cancer, with further research planned for other types of cancer.

2 months ago
10 Articles